Navigation Links
Vaccine for Asbestos-Related Cancer Looks Safe
Date:3/4/2010

In tests, novel immunotherapy appears to combat mesothelioma tumors

THURSDAY, March 4 (HealthDay News) -- An investigational vaccine for the asbestos-related cancer mesothelioma is safe, according to a new study.

Researchers in the Netherlands tested the vaccine -- which infuses a patient's own dendritic cells with antigen from the patient's tumor -- on 10 patients and found that it induced an immune T-cell response against mesothelioma tumors.

This is the first time DC-based immunotherapy has been tested in patients with mesothelioma, which typically occurs in the lungs but can arise at other body sites. The study was published online March 4 in advance of an upcoming print issue of the American Journal of Respiratory and Critical Care Medicine.

Asbestos has been banned in developed countries for decades, but the incidence of mesothelioma is expected to continue to increase until 2020. Median survival after mesothelioma diagnosis is about 12 months. The standard chemotherapy treatment improves survival by about three months.

"The possibility to harness the potency and specificity of the immune system underlies the growing interest in cancer immunotherapy," study author Dr. Joachim Aerts, a pulmonary physician at Erasmus Medical Center, said in a news release. "One such approach uses the patient's own [dendritic cells] to present tumor-associated antigens and thereby generate tumor-specific immunity."

Dendritic cells are a form of immune system cell.

"The major problem in mesothelioma is that the immunosuppressive environment caused by the tumor will negatively influence our therapy so we are now working on a method to lower this immunosuppressive environment," Aerts said. "We hope that by further development of our method it will be possible to increase survival in patients with mesothelioma and eventually vaccinate persons who have been in contact with asbestos to prevent them from getting asbestos related diseases."

More information

The U.S. National Cancer Institute has more about mesothelioma.



-- Robert Preidt



SOURCE: American Thoracic Society, news release, March 4, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Groundbreaking research to find vaccine for hepatitis C
2. Possible vaccine for mesothelioma proven safe
3. The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies Failure to Provide Adequate Safety Research
4. Texas-based consortium announces groundbreaking vaccine research program
5. New Technology Could Widen Reach of Vaccines
6. Screens, Vaccine for HPV Less Beneficial in Older Women
7. New strategy produces promising advance in cancer vaccines
8. Vaccine Not Fail-Safe in Ongoing Mumps Outbreak
9. Vaccine May Prevent TB in People With HIV
10. Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an Effective Malaria Vaccine
11. UM School of Medicine scientists find new malaria vaccine is safe and promotes immune response in children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Walton Beach, Florida (PRWEB) , ... February 10, ... ... the innovative weather-forecasting company is unveiling its revolutionary new 2.0 version at the ... platform, MetLoop has “put the power of the world's most advanced weather technology ...
(Date:2/10/2016)... TX (PRWEB) , ... February 10, 2016 , ... ... commencement of a master charity program created to assist the local community. Pledging ... with community leaders and nonprofit organizations in the area. Their goal is to ...
(Date:2/10/2016)... AZ (PRWEB) , ... February 10, 2016 , ... Ongoing ... the Aging Life Care Association™ (ALCA) to conduct a survey that takes a closer ... experts released today illustrates the prevalence and causes of TBI among the aging population, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience ... across their network of laboratory service centers across the country. Launched in April of ... in the detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... announced that it has been awarded the prestigious Distinguished Emerald Club of the ... program conducted by BoardRoom magazine, one of the most respected trade publications serving ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 ... "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market ... Technologies, Participants, and Environment" research report indicates that ... over $149 billion by 2020 growing at a ... of companion diagnostics and targeted therapeutics and is ...
(Date:2/9/2016)... CITY, Calif. , Feb. 9, 2016 /PRNewswire/ - ... device company that is providing innovative evidence-based solutions for ... will release financial results for the fourth quarter and ... February 29, 2016. Company management will host a conference ... Eastern Time) on Monday, February 29, 2016. ...
(Date:2/9/2016)... BILLERICA, Mass. , Feb. 9, 2016  Insulet Corporation ... in tubeless insulin pump technology with its OmniPod ... David A. Lemoine has been appointed to Insulet,s ... comprised of nine directors, eight of whom are independent. ... over 40 years of audit and finance experience and a ...
Breaking Medicine Technology: